All terms in DRUGBANK

Label Id Description
Bexagliflozin DB12236 [Bexagliflozin is under investigation for the treatment of Type 2 Diabetes Mellitus. Bexagliflozin has been investigated for the treatment of Diabetes Mellitus and Type2 Diabetes Mellitus.]
Desaspidin DB13567
Diodone DB13568
GW-274150 DB12237 [GW274150 has been used in trials studying the treatment and prevention of Asthma, Migraine, Migraine Disorders, and Arthritis, Rheumatoid.]
Retagliptin DB14898 [Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).]
Bunazosin DB12230 [Bunazosin has been used in trials studying the treatment of High Blood Pressure.]
Clobenzorex DB13561
Spartalizumab DB14892 [Spartalizumab is under investigation in clinical trial NCT02605967 (Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma).]
Temefos DB12231 [Diphos has been used in trials studying the treatment of Plasmodium Falciparum Malaria.]
Vibegron DB14895 [Vibegron is under investigation in clinical trial NCT03806127 (Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome).]
KRN-7000 DB12232 [KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT.]
Norgestrienone DB13563
Iguratimod DB12233 [Iguratimod is under investigation in Rheumatoid Arthritis.]
Zipeprol DB13564
Galicaftor DB14894 [Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.).]
Vobarilizumab DB14891 [Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).]
Dextranomer DB13560
Obicetrapib DB14890 [Obicetrapib is under investigation in clinical trial NCT02241772 (A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)).]
Sulfanilamide DB00259 [Sulfanilamide is a molecule containing the sulfonamide functional group attached to an aniline.]
Lymecycline DB00256 [A tetracycline with a 7-chloro substitution.]